Dermatofibroma is a clonal proliferative disease

Tse Ching Chen, Tseng tong Kuo*, Heng Leong Chan

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

70 Scopus citations

Abstract

Benign fibrous histiocytoma of the skin or dermatofibroma (DF) has been regarded as a fibrohistiocytic tumor. Whether DF is a neoplastic growth or a reactive process has not been settled. Since a neoplastic process is clonal in nature, clonal analysis of DF was conducted to see if DF is a clonal disease. Fresh specimens of 13 DFs and 2 hypertrophic scars obtained from female patients were studied. The adjacent nonlesional skin tissues served as controls. The clonal analysis was based on the methylation pattern of the polymorphic X-chromosome linked androgen-receptor gene (HUMARA). Eight DFs and 1 hypertrophic scar were heterozygous at the androgen receptor gene and could be analyzed. All 8 informative DFs showed a significant reduction in one of the allelic bands compared with the corresponding bands of the nonlesional tissue after Hha I digestion. Therefore, DF is a clonal proliferative disease. In contrast, 1 hypertrophic scar showed a polyclonal pattern of X-chromosome inactivation. We conclude that DF is a clonal disease favoring a neoplastic process.

Original languageEnglish
Pages (from-to)36-39
Number of pages4
JournalJournal of Cutaneous Pathology
Volume27
Issue number1
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Dive into the research topics of 'Dermatofibroma is a clonal proliferative disease'. Together they form a unique fingerprint.

Cite this